SCHEMBL248584

SCHEMBL248584

CCCCCCCCCCCCCC(=O)NNCCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.61
HDAC1 Q13547 1/20 0.61
HDAC2 Q92769 1/20 0.61
HSP90AA1 P07900 1/20 0.57
FAAH O00519 6/20 0.55
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
MAPK1 P28482 1/20 0.52
DNM1 Q05193 2/20 0.50
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
CASP2 P42575 1/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
GPR84 Q9NQS5 2/20 0.46
PPARG P37231 2/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249559 1.00 HDAC3 (0.61) HDAC3HDAC1HDAC2HSP90AA1FAAH
SCHEMBL119271 1.00 HDAC3 (0.61) HDAC3HDAC1HDAC2HSP90AA1FAAH
SCHEMBL4662735 1.00 HDAC3 (0.61) HDAC3HDAC1HDAC2HSP90AA1FAAH
SCHEMBL4629704 1.00 HDAC3 (0.61) HDAC3HDAC1HDAC2HSP90AA1FAAH
SCHEMBL2416986 1.00 HDAC3 (0.61) HDAC3HDAC1HDAC2HSP90AA1FAAH
Iodide SCHEMBL28676977 0.98 HDAC3 (0.59) HDAC3HDAC1HDAC2HSP90AA1FAAH
Hydrochloric Acid SCHEMBL16443869 0.98 HDAC3 (0.59) HDAC3HDAC1HDAC2HSP90AA1FAAH
Hydrochloric Acid SCHEMBL11128124 0.98 HDAC3 (0.59) HDAC3HDAC1HDAC2HSP90AA1FAAH
Hydrochloric Acid SCHEMBL14742603 0.98 HDAC3 (0.59) HDAC3HDAC1HDAC2HSP90AA1FAAH
SCHEMBL28720559 0.98 HDAC3 (0.59) HDAC3HDAC1HDAC2HSP90AA1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448354-B1 POST-FOAMING MILD CLEANSING COMPOSITION PZ CUSSONS INT LTD (GB) 2025-07-16 EP claimed
EP-3717607-B1 CLEANSING COMPOSITIONS AND USE THEREOF COLGATE PALMOLIVE CO (US) 2023-05-10 EP claimed
EP-3256527-B1 A SHEET MATERIAL WITH A CELLULAR STRUCTURE AND/OR A PROCESS FOR PRODUCING SAME ACOUSTIC SPACE PTY LTD (AU) 2022-07-27 EP claimed
EP-3092214-B1 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC SURFACTANTS N V (BE) 2018-06-20 EP claimed
EP-2797669-B1 CONDITIONING DYEING AGENT FOR KERATINOUS FIBRES HENKEL AG & CO KGAA (DE) 2018-04-04 EP claimed
EP-2770835-B1 SPORICIDAL FORMULATION INCLUDING AMINE OXIDE SURFACTANT AND A MIXTURE OF OXIDANTS KIMBERLY CLARK CO (US) 2017-06-21 EP claimed
EP-3092214-A2 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC Surfactants N.V. (BE) 2016-11-16 EP claimed
WO-2015104673-A9 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC SURFACTANTS NV (BE) 2016-01-07 WO claimed
EP-1874914-B1 LIQUID DETERGENT COMPOSITION COLGATE PALMOLIVE CO (US) 2012-09-26 EP claimed
US-11643589-B2 Methods and compositions for hydrocarbon recovery HALLIBURTON ENERGY SERVICES, INC. (US) 2023-05-09 US disclosed
US-20210355370-A1 METHODS AND COMPOSITIONS FOR HYDROCARBON RECOVERY HALLIBURTON ENERGY SERVICES, INC. 2021-11-18 US disclosed
EP-3849505-A1 A HAIR CARE COMPOSITION Symrise AG (DE) 2021-07-21 EP disclosed
WO-2021104645-A1 RIM BLOCK WITH IMPROVED SCENT PERFORMANCE SYMRISE AG (DE) 2021-06-03 WO disclosed
WO-2021073775-A1 ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN SYMRISE AG (DE) 2021-04-22 WO disclosed
EP-3092214-B1 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC SURFACTANTS N V (BE) 2018-06-20 EP disclosed
EP-3092214-A2 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC Surfactants N.V. (BE) 2016-11-16 EP disclosed
WO-2015104673-A9 NITROSAMINE/NITRITE INHIBITION IN TERTIARY ALKYLAMINE OXIDE COMPOSITIONS EOC SURFACTANTS NV (BE) 2016-01-07 WO disclosed
EP-2588117-A1 STABLE ANTISEPTIC COMPOSITIONS AND METHODS 3M Innovative Properties Company (US) 2013-05-08 EP disclosed
WO-2012002943-A1 STABLE ANTISEPTIC COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-05 WO disclosed
US-20090226541-A1 METHODS OF REDUCING MICROBIAL CONTAMINATION 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226541-A1 METHODS OF REDUCING MICROBIAL CONTAMINATION LPO, CAT, UNG HDAC3 2953/4885HDAC1 2627/4885HDAC2 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.